Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2000-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bone marrow that has been treated to remove certain white blood cells may be able
to replace immune cells that were destroyed by chemotherapy or radiation therapy, and may
reduce the chance of developing graft-versus-host disease following bone marrow
transplantation.
PURPOSE: Phase IV trial to study the incidence of graft-versus-host disease in patients who
have hematologic cancer and who are undergoing bone marrow transplantation from a donor.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore